EPS for MasTec, Inc. (MTZ) Expected At $0.18; CASTLIGHT HEALTH (CSLT) Sentiment Is 1.23

April 23, 2018 - By Ellis Scott

Castlight Health, Inc. (NYSE:CSLT) Logo

CASTLIGHT HEALTH (CSLT) investors sentiment decreased to 1.23 in 2017 Q4. It’s down -0.82, from 2.05 in 2017Q3. The ratio is negative, as 38 institutional investors opened new or increased stock positions, while 31 trimmed and sold holdings in CASTLIGHT HEALTH. The institutional investors in our database now own: 46.25 million shares, up from 44.86 million shares in 2017Q3. Also, the number of institutional investors holding CASTLIGHT HEALTH in top ten stock positions was flat from 0 to 0 for the same number . Sold All: 10 Reduced: 21 Increased: 22 New Position: 16.

Analysts expect MasTec, Inc. (NYSE:MTZ) to report $0.18 EPS on May, 3.They anticipate $0.38 EPS change or 67.86% from last quarter’s $0.56 EPS. MTZ’s profit would be $14.56M giving it 62.29 P/E if the $0.18 EPS is correct. After having $0.41 EPS previously, MasTec, Inc.’s analysts see -56.10% EPS growth. The stock increased 0.67% or $0.3 during the last trading session, reaching $44.85. About 10,480 shares traded. MasTec, Inc. (NYSE:MTZ) has risen 20.29% since April 23, 2017 and is uptrending. It has outperformed by 8.74% the S&P500.

It closed at $3.6 lastly. It is down 6.15% since April 23, 2017 and is uptrending. It has underperformed by 5.40% the S&P500.

Castlight Health, Inc. operates a health benefits platform in the United States. The company has market cap of $486.99 million. The companyÂ’s platform engages employees to make better health decisions and enables employers to communicate and measure their benefit programs. It currently has negative earnings. The Company’s platform also provides real-time insight into employee engagement with benefits and programs enabling employers to monitor and adjust their strategies.

Analysts await Castlight Health, Inc. (NYSE:CSLT) to report earnings on May, 10 after the close. They expect $-0.11 EPS, 0.00% or $0.00 from last year’s $-0.11 per share. After $-0.05 actual EPS reported by Castlight Health, Inc. for the previous quarter, Wall Street now forecasts 120.00% negative EPS growth.

Since January 1, 0001, it had 0 insider purchases, and 4 sales for $120,817 activity.

Gagnon Advisors Llc holds 2.48% of its portfolio in Castlight Health, Inc. for 901,394 shares. Gagnon Securities Llc owns 1.47 million shares or 1.96% of their US portfolio. Moreover, Selz Capital Llc has 0.41% invested in the company for 734,000 shares. The United Kingdom-based Wellcome Trust Ltd (The) As Trustee Of The Wellcome Trust has invested 0.37% in the stock. Allen Operations Llc, a New York-based fund reported 157,372 shares.

MasTec, Inc., an infrastructure construction company, provides engineering, building, installation, maintenance, and upgrade services for communications, energy, and utility infrastructure primarily in the United States and Canada. The company has market cap of $3.63 billion. It operates through five divisions: Communications, Oil and Gas, Electrical Transmission, Power Generation and Industrial, and Other. It has a 10.63 P/E ratio. The firm manufactures underground and overhead distribution systems, including trenches, conduits, cable, and power lines, which provide wireless and wireline/fiber communications; crude oil, natural gas, and refined product transport pipelines; electrical power generation, transmission, and distribution systems; power generation infrastructure, such as renewable energy; heavy industrial plants; and compressor and pump stations, and treatment plants.

Since February 1, 2018, it had 0 buys, and 4 insider sales for $4.40 million activity. JOHNSON JULIA L also sold $764,963 worth of MasTec, Inc. (NYSE:MTZ) shares. Apple Robert E sold $1.38 million worth of stock or 25,000 shares. $743,190 worth of stock was sold by de Cardenas Alberto on Thursday, March 1.

MasTec, Inc. (NYSE:MTZ) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>